VMD-928 100 mg Tablet

6 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

VMD-928 100 mg Tablet
Treatment and conditionWhere it standsTrials
VMD-928 100 mg Tablet for carcinoma, adenoid cysticPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
VMD-928 100 mg Tablet for laryngeal diseasesPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
VMD-928 100 mg Tablet for mesotheliomaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
VMD-928 100 mg Tablet for neoplasm metastasisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
VMD-928 100 mg Tablet for squamous cell carcinoma of head and neckPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
VMD-928 100 mg Tablet for tracheal diseasesPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1